Ginkgo Bioworks Holdings, Inc. (DNA)
NYSE: DNA · Real-Time Price · USD
8.70
+0.39 (4.69%)
At close: Jan 2, 2026, 4:00 PM EST
8.79
+0.09 (1.03%)
After-hours: Jan 2, 2026, 7:57 PM EST
Ginkgo Bioworks Holdings Market Cap
Ginkgo Bioworks Holdings has a market cap or net worth of $494.48 million as of January 2, 2026. Its market cap has decreased by -1.32% in one year.
Market Cap
494.48M
Enterprise Value
455.48M
1-Year Change
-1.32%
Ranking
Category
Stock Price
$8.70
Market Cap Chart
Since April 19, 2021, Ginkgo Bioworks Holdings's market cap has decreased from $2.18B to $494.48M, a decrease of -77.34%. That is a compound annual growth rate of -27.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 31, 2025 | 472.31M | -9.39% |
| Dec 31, 2024 | 521.27M | -84.36% |
| Dec 29, 2023 | 3.33B | 16.75% |
| Dec 30, 2022 | 2.86B | -76.89% |
| Dec 31, 2021 | 12.35B | 466.18% |
| Apr 19, 2021 | 2.18B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 967.64B |
| Johnson & Johnson | 499.21B |
| AbbVie | 406.00B |
| UnitedHealth Group | 299.99B |
| AstraZeneca | 288.12B |
| Novartis AG | 266.00B |
| Merck & Co. | 261.70B |
| Novo Nordisk | 227.63B |